Bioinformatics AdvancesBioinformaticsPeer-reviewed journal article
Leveraging Uncertainty Estimates for Drug Response Prediction in Cancer Cell Lines
Abstract
Machine learning models for drug response prediction in cancer cell lines carry the potential to advance precision oncology by tailoring treatments to the molecular tumor profile. Their application is challenged by variability in prediction quality and distribution shifts between training and application. Uncertainty estimation provides more information on the predictive distribution than point estimates, enabling comprehensive decision support and downstream analysis of predictions. Yet, the most effective uncertainty estimator is domain-specific. In this work, we benchmark uncertainty-aware models for drug response prediction. We focus on epistemic uncertainty via ensemble agreement, and aleatoric uncertainty via distributional modeling, or both. We find that ensemble-based estimates are more sensitive to distribution shift and can flag out-of-distribution examples. In contrast, distributional models yield stronger prediction error reductions among high-confidence subsets. Despite higher computational cost, the combination can provide both advantages: an ensemble of neural networks that estimate a Gaussian predictive distribution can reduce the mean squared error by 64 percent when restricting predictions to the 10 percent most confident drug-cell line pairs, and reliably indicates distribution shifts and platform differences. Beyond benchmarking, probabilistic predictions can identify drugs whose uncertainty bounds overlap with therapeutically relevant ranges. We also show that uncertainty estimates enable a new dimension of model interpretability: by attributing predicted uncertainty to input features, we identify genes that signal unpredictability of drug response rather than sensitivity or resistance. We further demonstrate uncertainty-guided selection of measurements for active learning. In summary, including uncertainty in drug response prediction supports better-informed model application. The code is available at https://github.com/PascalIversen/LUDRP.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 24th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- From Hype to Health Check: Critical Evaluation of Drug Response Prediction Models with DrEval
Judith Bernett, Pascal Iversen, … Markus List·bioRxiv·May 26, 2025
- The Specification Game: Rethinking the Evaluation of DrugResponse Prediction for Precision Oncology
Francesco Codicè, Corrado Pancotti, … Daniele Raimondi·Journal of CheminformaticsPeer-reviewed·Mar 14, 2025
- Calibrated Uncertainty Quantification for Patient-Level AML Drug Sensitivity Prediction Using Split Conformal Prediction
Amir J Shokrzadeh, Pegah Shokrzadeh·bioRxiv·Jun 11, 2026
- A Survey and Systematic Assessment of Computational Methods for Drug Response Prediction
Jinyu Chen, Louxin Zhang·Briefings in BioinformaticsPeer-reviewed·Nov 23, 2019
- Treatment response prediction: Is model selection unreliable?
David Augustin, Ken Wang, … David J. Gavaghan·bioRxiv·Mar 19, 2022
- A statistical framework for assessing pharmacological response and biomarkers using uncertainty estimates
D. Wang, J. Hensman, … F. Dondelinger·bioRxiv·May 1, 2020